M-L Dahl

1.1k total citations
11 papers, 711 citations indexed

About

M-L Dahl is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, M-L Dahl has authored 11 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Psychiatry and Mental health and 2 papers in Pharmacology. Recurrent topics in M-L Dahl's work include Pharmacogenetics and Drug Metabolism (7 papers), Schizophrenia research and treatment (3 papers) and Tryptophan and brain disorders (2 papers). M-L Dahl is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Schizophrenia research and treatment (3 papers) and Tryptophan and brain disorders (2 papers). M-L Dahl collaborates with scholars based in Sweden, United States and Russia. M-L Dahl's co-authors include Leif Bertilsson, Adrián LLerena, Gunnel Tybring, Ming Chang, Rein Seensalu, L. Lindström, Sara Ramos, Ulf Bondesson, J. Benítez and C. Alm and has published in prestigious journals such as Cancer Research, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

M-L Dahl

10 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M-L Dahl Sweden	8	409	222	159	123	104	11	711
C. Alm Sweden	12	413 1.0×	185 0.8×	123 0.8×	129 1.0×	152 1.5×	15	764
Leif Bertilsson Sweden	10	607 1.5×	85 0.4×	267 1.7×	140 1.1×	145 1.4×	11	933
Jolanta Widén Sweden	9	297 0.7×	108 0.5×	110 0.7×	96 0.8×	114 1.1×	9	488
Michael S. Ching Australia	18	295 0.7×	101 0.5×	170 1.1×	195 1.6×	134 1.3×	48	893
Marja-Liisa Dahl Sweden	13	740 1.8×	147 0.7×	307 1.9×	129 1.0×	231 2.2×	15	970
Dong‐Ryul Sohn South Korea	15	380 0.9×	87 0.4×	224 1.4×	110 0.9×	134 1.3×	27	864
H.‐U. Schulz Germany	15	239 0.6×	107 0.5×	154 1.0×	166 1.3×	119 1.1×	49	912
P. Arvela Finland	17	276 0.7×	125 0.6×	184 1.2×	197 1.6×	65 0.6×	49	826
Masayoshi Tani Japan	16	333 0.8×	61 0.3×	205 1.3×	88 0.7×	92 0.9×	29	825
P Bechtel France	15	495 1.2×	126 0.6×	201 1.3×	110 0.9×	198 1.9×	55	935

Countries citing papers authored by M-L Dahl

Since Specialization

Citations

This map shows the geographic impact of M-L Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M-L Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M-L Dahl more than expected).

Fields of papers citing papers by M-L Dahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M-L Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M-L Dahl. The network helps show where M-L Dahl may publish in the future.

Co-authorship network of co-authors of M-L Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of M-L Dahl. A scholar is included among the top collaborators of M-L Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M-L Dahl. M-L Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Haslemo, Tore, et al.. (2012). Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients. The Pharmacogenomics Journal. 13(6). 544–550. 25 indexed citations

Margolin, Sara, Jonatan D. Lindh, L Thorén, et al.. (2012). Abstract PD10-09: CYP2D6 and adjuvant tamoxifen: Impact on outcome in pre- but not postmenopausal breast cancer patients. Cancer Research. 72(24_Supplement). PD10–9.

Dahl, M-L, et al.. (2007). Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin. Clinical Pharmacology & Therapeutics. 84(1). 52–62. 70 indexed citations

Hamberg, Anna‐Karin, M-L Dahl, M.G. Scordo, et al.. (2007). A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy. Clinical Pharmacology & Therapeutics. 81(4). 529–538. 116 indexed citations

Dalen, P.A. Van, M-L Dahl, Gunnel Tybring, et al.. (2003). Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians. British Journal of Clinical Pharmacology. 55(6). 630–634. 13 indexed citations

Finnström, Niklas, et al.. (2002). Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes. The Pharmacogenomics Journal. 2(2). 111–116. 37 indexed citations

Chang, Ming, et al.. (1995). Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19.. British Journal of Clinical Pharmacology. 39(5). 511–518. 166 indexed citations

LLerena, Adrián, et al.. (1995). Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.. British Journal of Clinical Pharmacology. 40(5). 467–476. 47 indexed citations

Bertilsson, Leif, M-L Dahl, Adrián LLerena, et al.. (1994). Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.. British Journal of Clinical Pharmacology. 38(5). 471–473. 234 indexed citations

10.

Ingelman‐Sundberg, Magnus, Inger Johansson, M-L Dahl, et al.. (1992). [Genotyping for drug metabolism capacity can give valuable clinical information].. PubMed. 89(19). 1675–8. 2 indexed citations

11.

Dahl, M-L, Tapio Puustinen, & Pekka Uotila. (1984). U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.. PubMed. 44(3). 355–65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact